ES8206976A1 - Procedimiento para la obtencion de una vacuna neumococica - Google Patents

Procedimiento para la obtencion de una vacuna neumococica

Info

Publication number
ES8206976A1
ES8206976A1 ES506359A ES506359A ES8206976A1 ES 8206976 A1 ES8206976 A1 ES 8206976A1 ES 506359 A ES506359 A ES 506359A ES 506359 A ES506359 A ES 506359A ES 8206976 A1 ES8206976 A1 ES 8206976A1
Authority
ES
Spain
Prior art keywords
obtaining
translation
procedure
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506359A
Other languages
English (en)
Other versions
ES506359A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Priority to ES506359A priority Critical patent/ES506359A0/es
Publication of ES8206976A1 publication Critical patent/ES8206976A1/es
Publication of ES506359A0 publication Critical patent/ES506359A0/es
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UNA VACUNA NEUMOCOCICA. CONSISTE EN OBTENER UN POLISACARIDO CAPSULAR POR CULTIVO DE UNA CEPA DE NEUMOCOCO EN UN MEDIO ADECUADO, NEUTRALIZAR POR ADICION DE HIDROXIDO SODICO, PROVOCAR LA LISIS CELULAR CONTRA UN VOLUMEN MINIMO DE AGUA DIEZ VECES EL VOLUMEN DEL CULTIVO. EL MATERIAL NO DIALIZADO SE RECUPERA POR LIOFILIZACON Y SE REDISULVE EN ACETATO SODICO AL 5 POR 100; SE SEPARA, POR CENTRIFUGACION, EL MATERIAL INSOLUBLE, SE RECOGE EL SOBRENADANTE, SE AÑADE LA MITAD DE SU VOLUMEN DE ALCOHOL ABSOLUTO Y SE MEZCLA. ESTA VACUNA TIENE APLICACIONES FARMACOLOGICAS EN LA TERAPIA PREVENTIVA DE ENFERMEDADES INFECCIOSAS ORIGINADAS POR "STREPTOCOCCUS PNEUMONIAE".
ES506359A 1981-10-20 1981-10-20 Procedimiento para la obtencion de una vacuna neumococica Granted ES506359A0 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES506359A ES506359A0 (es) 1981-10-20 1981-10-20 Procedimiento para la obtencion de una vacuna neumococica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES506359A ES506359A0 (es) 1981-10-20 1981-10-20 Procedimiento para la obtencion de una vacuna neumococica

Publications (2)

Publication Number Publication Date
ES8206976A1 true ES8206976A1 (es) 1982-08-16
ES506359A0 ES506359A0 (es) 1982-08-16

Family

ID=8483096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506359A Granted ES506359A0 (es) 1981-10-20 1981-10-20 Procedimiento para la obtencion de una vacuna neumococica

Country Status (1)

Country Link
ES (1) ES506359A0 (es)

Also Published As

Publication number Publication date
ES506359A0 (es) 1982-08-16

Similar Documents

Publication Publication Date Title
FI912878A0 (fi) Pneumolysinmutanter och pneumokockala vaksiner tillvarkade av dem.
IE791618L (en) Pasteurellosis vaccines.
EP0013983A3 (en) Antineoplastics on the basis of little or non-irritating diterpenalcohols,and derivatives thereof, and their preparation
ES475509A1 (es) Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae.
IT1211116B (it) Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina.
JPS567724A (en) Blend and its manufacture
DE2961091D1 (en) E. coli enterotoxin vaccine for veterinary & human use and process for its preparation
CA2044421A1 (en) Squamous cell carcinoma-like immunoreactive antigen from human female urine
IE37038L (en) Preparation 3, 4, 5, trimethoxybenzaldehyde
ES8206976A1 (es) Procedimiento para la obtencion de una vacuna neumococica
JPS57181072A (en) Oxaprodine derivative
SE8401263D0 (sv) Analgesic preparations
SE8205247D0 (sv) Fiskvacciner
CA1007636A (en) Process for the simultaneous diazotisation and coupling of o-nitroanilines and water-insoluble 2,4-disubstituted phenols
BE857794A (fr) Vaccin contre la maladie de l'oedeme de porcelet
ZA805310B (en) Process for the preparation of alcohols or aldehydes, alcohols or aldehydes prepared by this process and stabilized compositions suitable for use in the said process
JPS5261214A (en) Preparation of anti-tumor substance
IL57905A (en) 6-isothiocyano-5-methoxy-2-tert.butyl-benzothiazole,its preparation and use as anthelmintic
DK158033C (da) Fremgangsmaade til afgiftning af e.coli neurotoxin og fremgangsmaade til fremstilling af en vaccine mod oedemsygdom hos smaagrise
Yamamoto Studies on the causative agent of Hyuga-feveri; cultivation of rickettsia-like organisms isolated from metacercariae of Stellantchasumus falcatus in tissue culture cell and their antigenic relation to Rickettsia sennetsu (author's transl)
IL48384A0 (en) The isolation and purification of an e.coli toxin,the pure product thus obtained and vaccines comprising it
GB1528883A (en) Composition for treating tumours and difficultly curable skin diseases
JPS5366441A (en) Antibacterial agent for fish
ES486579A1 (es) Un procedimiento para preparar una vacuna intra-respiratoria
JPS548155A (en) Pipe extander